Cargando…
Upfront Advanced Radiotherapy and New Drugs for NSCLC Patients with Synchronous Brain Metastases: Is the Juice Worth the Squeeze? A Real-World Analysis from Lombardy, Italy
SIMPLE SUMMARY: This study aims to compare effectiveness and cost profile in non-small-cell lung cancer (NSCLC) patients harboring synchronous brain metastases (BMs) who received non-chemo first-line systemic therapy with or without advanced radiotherapy (aRT). A total of 177 lung cancer patients, o...
Autores principales: | Corrao, Giulia, Franchi, Matteo, Zaffaroni, Mattia, Vincini, Maria Giulia, de Marinis, Filippo, Spaggiari, Lorenzo, Orecchia, Roberto, Marvaso, Giulia, Jereczek-Fossa, Barbara Alicja |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9953825/ https://www.ncbi.nlm.nih.gov/pubmed/36831447 http://dx.doi.org/10.3390/cancers15041103 |
Ejemplares similares
-
Unraveling Mitochondrial Determinants of Tumor Response to Radiation Therapy
por: Zaffaroni, Mattia, et al.
Publicado: (2022) -
Automatic Segmentation with Deep Learning in Radiotherapy
por: Isaksson, Lars Johannes, et al.
Publicado: (2023) -
COVID-19 impact in radiotherapy practice in an oncology hub: a screenshot from Lombardy, Italy
por: Corrao, Giulia, et al.
Publicado: (2020) -
Commentary: Is the juice worth the squeeze?
por: Demmy, Todd L.
Publicado: (2020) -
Commentary: Is the juice worth the squeeze?
por: Lantz, Gurion, et al.
Publicado: (2021)